BioCryst Pharmaceuticals
BCRX
#5063
Rank
NZ$2.76 B
Marketcap
NZ$13.12
Share price
-0.59%
Change (1 day)
-0.54%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$1.44 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$1.44 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$1.71 B11.43%
2023-12-31NZ$1.53 B15.6%
2022-12-31NZ$1.33 B30.71%
2021-12-31NZ$1.01 B107.45%
2020-12-31NZ$0.49 B141.11%
2019-12-31NZ$0.20 B39.83%
2018-12-31NZ$0.14 B9.37%
2017-12-31NZ$0.13 B4.41%
2016-12-31NZ$0.12 B16.86%
2015-12-31NZ$0.10 B39.52%
2014-12-31NZ$78.15 M28.48%
2013-12-31NZ$60.83 M-13.56%
2012-12-31NZ$70.37 M-18.51%
2011-12-31NZ$86.36 M51.62%
2010-12-31NZ$56.96 M-26.02%
2009-12-31NZ$76.99 M16.77%
2008-12-31NZ$65.93 M-35.09%
2007-12-31NZ$0.10 B51.2%
2006-12-31NZ$67.18 M12.53%
2005-12-31NZ$59.7 M1259.2%
2004-12-31NZ$4.39 M73.22%
2003-12-31NZ$2.53 M13.24%
2002-12-31NZ$2.23 M-59.26%
2001-12-31NZ$5.49 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Repligen
RGEN
NZ$1.45 B 0.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$3.75 B 160.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$2.25 M-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.30 B 60.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$64.05 B 4,344.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$86.51 M-94.00%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$105.88 B 7,245.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
NZ$1.51 B 5.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$22.99 M-98.40%๐Ÿ‡บ๐Ÿ‡ธ USA